최은경

  #폐암#흉선종#유방암(부분절제술)

학력


1990 .09 ~ 1992 .08서울대학교 의학 박사
1985 .03 ~ 1987 .02서울대학교 의학 석사
1977 .03 ~ 1983 .02서울대학교 의학 학사

경력

2010 .04 ~ 2013 .12서울아산병원 연구기획관리실장
2009 .03 ~ 2011 .02폐암센터 소장
2007 .03 ~ 2010 .02아산생명과학연구소 부소장
2002 .10 ~ 현재울산의대 서울아산병원 교수
1998 .09 ~ 2004 .08울산의대 주임교수, 서울아산병원 방사선종양학과장
1997 .10 ~ 2002 .09울산의대, 서울아산병원 방사선종양학과 부교수
1995 .08 ~ 1996 .08미국, UCSF 방사선생물학 연구 방문 교수
1993 .03 ~ 1997 .09울산의대, 서울아산병원 방사선종양학과 조교수
1990 .03 ~ 1993 .02울산의대, 서울아산병원 방사선종양학과 전임강사
1989 .03 ~ 1990 .02울산대학교 의과대학 서울아산병원 방사선종양학과 전임의
1988 .03 ~ 1989 .02서울대학교 의과대학 서울대학병원 치료방사선과 전임의
1987 .03 ~ 1988 .02대전을지병원 치료방사선과 과장
1984 .03 ~ 1987 .02서울대학교병원 레지던트
1983 .03 ~ 1984 .02서울대학교병원 인턴

논문

Establishment of a Patient-derived Xenograft for Development of Personalized HER2-targeting Therapy in Gastric Cancer.
Evaluation of delivered dose to a moving target by 4D dose reconstruction in gated volumetric modulated arc therapy
Feasible Optimization of Stereotactic Ablative Radiotherapy Dose by Tumor Size for Stage I Non-small-cell Lung Cancer.
Pyrrolidine dithiocarbamate reverses Bcl-xL-mediated apoptotic resistance to doxorubicin by inducing paraptosis.
The effect of escalating the boost dose for patients with involved resection margin after breast-conserving surgery.
A 10-year clinical outcome of radiotherapy as an adjuvant or definitive treatment for primary tracheal adenoid cystic carcinoma.
A strategy for actualization of active targeting nanomedicine practically functioning in a living body.
CD133 confers cancer stem-like cell properties by stabilizing EGFR-AKT signaling in hepatocellular carcinoma.
Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema.
Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer.
Effect of time interval between capecitabine intake and radiotherapy on local recurrence-free survival in preoperative chemoradiation for locally advanced rectal cancer.
Feasibility of Postoperative Radiotherapy Using Conventional Fractionation for Lymph Node Metastasis from Cutaneous Melanoma.
Impact of pathologic diagnosis of internal mammary lymph node metastasis in clinical N2b and N3b breast cancer patients.
Low immunogenic bio-nanocapsule based on hepatitis B virus escape mutants.
Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma.
PSMB8 as a Candidate Marker of Responsiveness to Preoperative Radiation Therapy in Rectal Cancer Patients.
Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin.
Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2.
Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus.
Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells.
TGF-β-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC.
Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids.
Application of peptide displaying phage as a novel diagnostic probe for human lung adenocarcinoma.
Hepatic reaction dose for parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images after stereotactic body radiation therapy for hepatocellular carcinoma.
Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytes.
Improving Delivery Accuracy of Stereotactic Body Radiotherapy to a Moving Tumor Using Simplified Volumetric Modulated Arc Therapy
Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer.
Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma.
Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging.
A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.

저서

암에 대한 모든 것 (가림건강신서 54)

보도자료

[여의열전](38) 최은경 서울아산병원 교수
http://news.khan.co.kr/kh_news/art_print.html?artid=201401092035405

대한방사선종양학회장 최은경 교수
http://www.hankyung.com/news/app/newsview.php?aid=2013102192171

포스팅

A Comparison of the Phase- and Amplitude- gated VMAT on lung SBRT using 3D-printed lung phantom
Treatment results of clinical N2b breast cancer patients
Cardiac dose reduction in breast irradiation using deep inspiration breath hold: dose comparison study based on deformable image registration
Gamma Knife Surgery (GKS) Alone versus GKS Followed by Whole Brain Radiotherapy (WBRT) as the Initial Treatment of Brain Metastasis
Can concurrent chemoradiotherapy replace surgery and postoperative radiation in locally advanced stage III/IV tonsillar carcinoma?
The prognostic role of standardized uptake value of pretreatment 18F-FDG PET and of early metabolic response after radioatherapy for nasopharyngeal carcinoma

영상자료

영상자료 내용이 없습니다.

발표자료

Simulation study on coverage of tumor motion accordance with the scanning time in slow-scan CT
Target localization accuracy using image guidance for liver stereotactic radiosurgery
Identification of neutron-induced isotopes in varian linac system
IGRT techniques in SRS
Enhancement of radiotherapeutic efficacy by active targeting of b-lapachone using Au nanoparticle
The effect of NQO1 polymorphisms on prognosis of non-small cell lung cancer after postoperative radiation therapy
Neoadjuvant weekly paclitaxel/cisplatin chemotherapy (WPC) with concurrent thoracic radiation (TR) followed by surgical resection (S) for pathologically proven N2 (pN2) stage IIIA non-small cell lung
Induction chemotherapy followed by concurrent chemoradiotherapy (CCRT) versus CCRT alone for unresectable stage III non-small cell lung cancer (NSCLC): randomized phase III trial.
Application of serum proteomic patterns in diagnosis of lung disease using the aptamer-based biochps
두개내 배아종의 방사선치료 결과
Concurrent Hypofractionated Intensity-modulated Radiation Therapy with Simultaneous Integrated Boost Technique and Temozolomide in Glioblastoma
Computer Tomography (CT) Based Treatment Planning in Cervical Cancer Brachytherapy: Analysis of Dose-Volume Histograms (DVHs)
Results of Definitive Chemoradiation Therapy for Unresectable Esophageal Cancer
Usefulness of FDG-PET.CT for Evaluation of Tumor Response after Stereotactic Radiosurgery in Primary or Metastatic Lung Cancer
절제 불가능한 식도암에서의 근치적 동시 항암화학 방사선치료의 성적과 재발 양상
Clinical Results of Stereotactic Body Frame Based Radiation Therapy for Primary or Metastatic Tumors in the Lung
Clinical Significance of 18FDG-PET Scan on Non-squamous Cell Carcinoma of the Head and Neck.
사지 육종의 수술 후 방사선 치료 성적
폐암 환자의 정위적방사선수술 시 CBCT를 이용한 On-line Setup
Prospective Randomized Phase Ⅲ Trial of KROG 03-02 on the Induction Chemotherapy in the Concurrent Chemoradiotherapy for the Locally Advanced Non-Small Cell Lung Cancer
Comparison of Various Respiration Measurement Methods for 4D Radiotherapy.
호흡동기방사선치료 전략: Phantom Study
Image-guided Radiation Therapy for Stereotatic Radiosurgery in Lung Tumor
Randomized Trial Comparing Monthly 5-flourouracil and Cisplatin to Weekly Cisplatin Alone Combined with Concurrent Radiotherapy for Locally Advanced Cervical Cancer
Intensity-modulated Radiotherapy for Nasopharyngeal Carcinoma in Asan Medical Center Experience
Concurrent Hypofractionated Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost Technique and Temozolomide in Glioblastoma
Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer
The Optimal Time Interval between Capecitabine Intake and Radiotherapy in Preoperatie Chemoradiation for Locally Advanced Rectal Cancer
The Effect of NQO1 Polymorphisms on Prognosis of Non-small Cell Lung Cancer after Postoperafive Radiation Therapy
Concerrent Hypofractionated Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost Technique and Temozolomide for Glioblastoma